Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0032285 (
pneumonia
)
54,520
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Streptococcus pneumoniae is the most common causative pathogen in community-acquired
pneumonia
.
Protease-activated receptor 2
(
PAR2
) is expressed by different cell types in the lungs and can mediate inflammatory responses. We sought to determine the role of
PAR2
during pneumococcal
pneumonia
. Pneumococcal pneumonia or sepsis was induced in wild-type and
PAR2
knock-out (Par2-/-) mice by infection with viable S. pneumoniae. Par2-/- mice demonstrated improved host defense, a largely preserved lung barrier integrity, and reduced mortality during pneumococcal
pneumonia
.
PAR2
deficiency did not influence bacterial growth after intravenous infection. Inhibition of the endogenous
PAR2
activating proteases tissue factor/factor VIIa or tryptase did not impact on bacterial burdens during
pneumonia
. In a
PAR2
reporter cell line it was demonstrated that S. pneumoniae-derived proteases are able to cleave
PAR2
. These results show that S. pneumoniae is able to cleave and exploit
PAR2
to disseminate systemically from the airways.
...
PMID:Protease-Activated Receptor 2 Facilitates Bacterial Dissemination in Pneumococcal Pneumonia. 2941 78